Publication Date
1-1-2022
Journal
Frontiers in Molecular Neuroscience
DOI
36533127
PMID
36533127
PMCID
PMC9751323
PubMedCentral® Posted Date
12-1-2022
PubMedCentral® Full Text Version
Post-Print
Published Open-Access
yes
Keywords
steroid receptor coactivator stimulation, transcriptional regulation, astrocytes, neuroprotection, cerebral ischemia, inflammation, oxidative stress
Abstract
Introduction: Pathologic remodeling of the brain following ischemic stroke results in neuronal loss, increased inflammation, oxidative stress, astrogliosis, and a progressive decrease in brain function. We recently demonstrated that stimulation of steroid receptor coactivator 3 with the small-molecule stimulator MCB-613 improves cardiac function in a mouse model of myocardial ischemia. Since steroid receptor coactivators are ubiquitously expressed in the brain, we reasoned that an MCB-613 derivative (MCB-10-1), could protect the brain following ischemic injury. To test this, we administered MCB-10-1 to rats following middle cerebral artery occlusion and reperfusion.
Methods: Neurologic impairment and tissue damage responses were evaluated on day 1 and day 4 following injury in rats treated with control or 10-1.
Results: We show that 10-1 attenuates injury post-stroke. 10-1 decreases infarct size and mitigates neurologic impairment. When given within 30 min post middle cerebral artery occlusion and reperfusion, 10-1 induces lasting protection from tissue damage in the ischemic penumbra concomitant with: (1) promotion of reparative microglia; (2) an increase in astrocyte NRF2 and GLT-1 expression; (3) early microglia activation; and (4) attenuation of astrogliosis.
Discussion: Steroid receptor coactivator stimulation with MCB-10-1 is a potential therapeutic strategy for reducing inflammation and oxidative damage that cause neurologic impairment following an acute ischemic stroke.
Included in
Endocrine System Diseases Commons, Endocrinology, Diabetes, and Metabolism Commons, Neurosciences Commons
Comments
Associated Data